Exhaled Breath, Blood Tests Differentiate Lung Diseases
Distinct lipid signatures identified in blood plasma and exhaled breath samples can differentiate between IPF and fibrotic hypersensitivity pneumonitis.
Distinct lipid signatures identified in blood plasma and exhaled breath samples can differentiate between IPF and fibrotic hypersensitivity pneumonitis.
Distinct lipid signatures identified in blood plasma and exhaled breath samples can differentiate between IPF and fibrotic hypersensitivity pneumonitis.
Read MoreOnly about 18% of eligible US adults underwent lung cancer screening in 2022, lagging far behind rates for breast and colorectal cancer screenings.
Read MoreThe new slim 5.9 mm diameter endobronchial ultrasound (EBUS) device is designed to access and sample tissue from hard-to-reach areas of the lungs.
Read MorePhilips Ultrasound has alerted users that all Lumify diagnostic ultrasound systems have updated use instructions, according to an FDA Early Alert.
Read MoreRT’s September-October 2026 Digital Edition discusses bronchiectasis care, bubble CPAP for chronic/acute neonatal conditions and standardizing asthma care.
Read MoreA new noninvasive approach combines imaging analysis and blood testing to evaluate indeterminate lung nodules.
Read MoreThe Sepsis ImmunoScore is the first sepsis artificial intelligence diagnostic tool authorized by the FDA and uses patient data to assess risk within 24 hours.
Read MoreResearchers are developing a noninvasive diagnostic protocol using breath analysis and cheek swabs to identify asthma before age 5.
Read MoreMedibyt’s CPETWise automated platform aims to cut cardiopulmonary exercise testing interpretation time in half and standardize clinical workflows.
Read MoreA national study finds significant inconsistency among doctors when interpreting lung sounds in children suspected of pediatric pneumonia.
Read MoreA national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
Read MoreCo-Diagnostics submitted a dual 510(k) premarket notification and CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV multiplex respiratory test.
Read MoreWearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.
Read MoreThe project from the American Thoracic Society aims to reduce the high rate of undiagnosed sleep disorders by partnering with primary care providers.
Read MoreOnly one-third (33%) of surveyed Americans were aware that low-dose CT scans are available individuals at high-risk of lung cancer.
Read MoreProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
Read MoreThe collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read MoreRT looks at some of the latest simulation technology available from IMT Analytics, Michigan Instruments and South Pacific Biomedical.
Read MoreA closer look as some of the latest spirometers and PFT devices on the market from Jaeger Medical, MGC Diagnostics, Vitalograph, and VacuMed.
Read MoreThe collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.
Read MoreA TB blood test identifies a bacterial marker to distinguish between active and latent tuberculosis infections.
Read MoreA standard laboratory assay significantly underestimates blood sugar levels in people with sickle cell trait, potentially leading to widespread underdiagnosis of diabetes.
Read MoreZepto Life Technology has introduced FungiFlex Pneumocystis jirovecii and the FungiFlex Mold Plus Panel testing assays.
Read MoreA study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.
Read More